Key terms

About INDP

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest INDP news

Apr 15 6:17am ET Buy Rating Affirmed for Indaptus Therapeutics Amidst Promising Clinical Advances and Potential Market Impact by TipRanks Apr 12 3:05pm ET Buy Rating for Indaptus Therapeutics: Promising Oncology Breakthrough with Decoy20 Platform by TipRanks Apr 11 7:32am ET Indaptus presents mechanism of action data at AACR for Decoy platform by TipRanks Mar 25 8:52am ET Indaptus Therapeutics previews presentation of mechanism of action data by TipRanks Mar 14 1:55pm ET Buy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial Outlook by TipRanks Mar 13 7:32am ET Indaptus Therapeutics expects cash to support activities through 3Q24 by TipRanks Mar 13 7:32am ET Indaptus Therapeutics reports 2023 EPS ($1.83) vs. ($1.73) last year by TipRanks Mar 06 2:15pm ET Buy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 with Promising Developments by TipRanks Mar 04 7:33am ET Indaptus announces results from second cohort in Phase 1 INDP-D101 trial by TipRanks Feb 08 8:09am ET Indaptus Therapeutics launches new social media initiative to provide education by TipRanks

No recent press releases are available for INDP

INDP Financials

1-year income & revenue

Key terms

INDP Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

INDP Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching